PACS:NYE-PACS Group, Inc. (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 42.93

Change

+0.70 (+1.66)%

Market Cap

N/A

Volume

0.57M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+0.25 (+0.07%)

USD 105.82B
UHS Universal Health Services Inc

+1.58 (+0.77%)

USD 15.62B
THC Tenet Healthcare Corporation

-4.68 (-2.88%)

USD 15.10B
DVA DaVita HealthCare Partners Inc

-17.09 (-10.80%)

USD 13.69B
EHC Encompass Health Corp

+1.34 (+1.34%)

USD 9.63B
CHE Chemed Corp

-74.00 (-12.14%)

USD 9.04B
CON Concentra Group Holdings Paren..

+0.56 (+2.77%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

-0.23 (-1.23%)

USD 2.59B
NHC National HealthCare Corporatio..

-3.06 (-2.51%)

USD 1.83B
AMN AMN Healthcare Services Inc

-1.10 (-2.71%)

USD 1.54B

ETFs Containing PACS

IDOG ALPS International Sector.. 2.11 % 0.50 %

-0.16 (-0.88%)

USD 0.30B
LDEU:LSE L&G Quality Equity Divide.. 1.13 % 0.00 %

-0.11 (-0.88%)

USD 0.04B
EFAS Global X MSCI SuperDivide.. 0.00 % 0.56 %

+0.03 (+-0.88%)

USD 0.01B
EXV8:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

-0.06 (-0.88%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike